Middle Meningeal Artery Embolization for the Management of Chronic Subdural Hematomas: A New-Old Treatment

Acta Neurochir Suppl. 2023:135:115-118. doi: 10.1007/978-3-031-36084-8_19.

Abstract

Chronic subdural hematoma (cSDH) is defined as a subdural collection of blood on CT imaging that tends to persist and gradually increase in volume over time, with components that are hypodense or isodense compared to the brain. There are no proven guidelines for the management of patients with cSDH. Surgical approaches included burr hole, twist drill hole, and craniotomy-based evacuations. Outcomes after surgical removal is generally favorable, but cSDH tends to recur after the initial evacuation.Middle meningeal artery (MMA) embolization has been gaining increasing popularity among the treatments of cSDH. This is largely due to a growing population of patients with cSDH who are refractory to other treatments or in patients who present with multiple comorbidities or who are taking antiplatelet and anticoagulant medications. The goal of middle meningeal artery (MMA) embolization is to devascularize subdural membranes associated with SDH so that the balance between continued leakage and reabsorption is shifted toward reabsorption.We discuss our clinical and technical approach to cSDH treated with perioperative embolization of the MMA.

Keywords: Chronic subdural hematoma; Embolization; Endovascular; Hematoma evacuation; Middle meningeal artery.

MeSH terms

  • Anticoagulants
  • Brain
  • Embolization, Therapeutic*
  • Hematoma, Subdural, Chronic* / diagnostic imaging
  • Hematoma, Subdural, Chronic* / therapy
  • Humans
  • Meningeal Arteries / diagnostic imaging

Substances

  • Anticoagulants